Subject [ETNEWS KOREA] Inthera Inc., Enhancing the Development Platform for VLNP-based Vaccines

Date2023-10-16Lookup193

• Prev [Maeil Business News Korea] CEO Interview - Accelerating the Development of Next-Generation VLP Vacc
• Next [Dongascience KOREA] CEO Interview - Why Government support is important in vaccine R&D of bio Ventu